{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:12:51Z","timestamp":1792872771796,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.xkme.2023.100769","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:32:47Z","timestamp":1701801167000},"page":"100769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia"],"prefix":"10.1016","volume":"6","author":[{"given":"Rose Mary","family":"Attieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chitty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Izzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-0524","authenticated-orcid":false,"given":"Kenar D.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.xkme.2023.100769_bib1","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","article-title":"Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions","volume":"104","author":"Valent","year":"2019","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.xkme.2023.100769_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.25104","article-title":"Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management","volume":"93","author":"Patnaik","year":"2018","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.xkme.2023.100769_bib4","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"},{"issue":"35","key":"10.1016\/j.xkme.2023.100769_bib5","doi-asserted-by":"crossref","first-page":"57021","DOI":"10.18632\/oncotarget.10937","article-title":"Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features","volume":"7","author":"Palomo","year":"2016","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.xkme.2023.100769_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ajh.26455","article-title":"Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Patnaik","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.xkme.2023.100769_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106640","article-title":"Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy","volume":"109","author":"Hunter","year":"2021","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00277-019-03708-9","article-title":"Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis","volume":"98","author":"Strati","year":"2019","journal-title":"Ann Hematol"},{"issue":"1-2","key":"10.1016\/j.xkme.2023.100769_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10354-022-00977-4","article-title":"Significance of reduced renal function in patients with chronic myelomonocytic leukemia","volume":"173","author":"Heschl","year":"2023","journal-title":"Wien Med Wochenschr"},{"issue":"12","key":"10.1016\/j.xkme.2023.100769_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2362.1994.tb02022.x","article-title":"Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome","volume":"24","author":"Bustos","year":"1994","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib12","first-page":"1303","article-title":"Acute kidney injury in a man with chronic myelomonocytic leukemia","volume":"35","author":"Sun","year":"2022","journal-title":"J\u00a0Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2023.100769_bib13","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1080\/1042819021000016186","article-title":"Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Saif","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.59.5.390","article-title":"Systemic vasculitis with bilateral perirenal haemorrhage in chronic myelomonocytic leukaemia","volume":"59","author":"Aslangul-Castier","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<200::AID-AJH6>3.0.CO;2-0","article-title":"Myelodysplastic syndromes with nephrotic syndrome","volume":"60","author":"Saitoh","year":"1999","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"B\u00fcttner-Herold","year":"2021","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib20","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1002\/ajh.26902","article-title":"Spectrum of renal pathological findings in patients with chronic myelomonocytic leukemia and kidney injury","volume":"98","author":"Gipe","year":"2023","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00428-021-03129-y","article-title":"Renal post-mortem findings in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms","volume":"479","author":"Person","year":"2021","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.revmed.2013.04.014","article-title":"The myeloproliferative neoplasms-related glomerulopathy","volume":"35","author":"Bardy","year":"2014","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0272-6386(12)80349-0","article-title":"Regulation of mesangial cell proliferation","volume":"17","author":"Floege","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.175.5.1413","article-title":"Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor","volume":"175","author":"Johnson","year":"1992","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.xkme.2023.100769_bib25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood-2018-11-876888","article-title":"Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis","volume":"133","author":"Fenaux","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1908892","article-title":"Luspatercept in patients with lower-risk myelodysplastic syndromes","volume":"382","author":"Fenaux","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"5-6","key":"10.1016\/j.xkme.2023.100769_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10428199509059648","article-title":"Glomerular injury in chronic myelomonocytic leukemia","volume":"18","author":"Morschhauser","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib28","first-page":"609","article-title":"Severe renal complications in chronic myelomonocytic leukemia","volume":"21","author":"Enriquez","year":"2008","journal-title":"J\u00a0Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ekir.2020.12.005","article-title":"Kidney involvement in patients with chronic myelomonocytic leukemia or BCR-ABL-negative myeloproliferative neoplasms","volume":"6","author":"Belliere","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s13730-020-00567-6","article-title":"A\u00a0rare cause of acute kidney injury with chronic myelomonocytic leukemia","volume":"10","author":"Asano","year":"2021","journal-title":"CEN Case Rep"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00432526","article-title":"Pathoanatomical features of the kidney in myelomonocytic and chronic lymphocytic leukemia","volume":"368","author":"Schwarze","year":"1975","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.1974.125","article-title":"Intralysosomal digestion of lysozyme in renal proximal tubule cells","volume":"6","author":"Christensen","year":"1974","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.124.5.921","article-title":"Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia","volume":"124","author":"Osserman","year":"1966","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"10.1016\/j.xkme.2023.100769_bib34","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1172\/JCI106387","article-title":"Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia","volume":"49","author":"Pruzanski","year":"1970","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.xkme.2023.100769_bib35","first-page":"407","article-title":"Progressive kidney failure in chronic myelomonocytic leukaemia: don\u2019t forget lysozyme damage","volume":"76","author":"Hillen","year":"2018","journal-title":"Neth J Med"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ekir.2016.09.002","article-title":"Lysozyme-induced nephropathy","volume":"2","author":"Santoriello","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib37","first-page":"47","article-title":"The relationship of lysozyme to the nephropathy in chloroleukemic rats and the effects of lysozyme loading on normal rat kidneys","volume":"34","author":"Klockars","year":"1974","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.xkme.2023.100769_bib38","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ekir.2023.05.007","article-title":"Clinicopathologic spectrum of lysozyme-associated nephropathy","volume":"8","author":"Kudose","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.kint.2020.06.028","article-title":"The case: acute kidney injury associated with chronic myelomonocytic leukemia","volume":"99","author":"Mohamadou","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.annpat.2020.04.001","article-title":"Lysozyme-induced nephropathy: a rare manifestation of chronic myelomonocytic leukaemia","volume":"40","author":"Robinet-Zimmermann","year":"2020","journal-title":"Ann Pathol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.16455","article-title":"Lysozyme-induced nephropathy: a rare manifestation of chronic myelomonocytic leukaemia","volume":"189","author":"Maraj","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.ajkd.2008.11.013","article-title":"A\u00a0forgotten cause of kidney injury in chronic myelomonocytic leukemia","volume":"54","author":"Patel","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib43","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/ccr3.2188","article-title":"Lysozyme nephropathy in chronic myelomonocytic leukemia","volume":"7","author":"Patel","year":"2019","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib44","article-title":"Lysozyme-induced nephropathy: a diagnosis not to forget","volume":"15","author":"Paulo","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/nep.13056","article-title":"Lysozyme nephropathy in haematologically stable chronic myelomonocytic leukaemia","volume":"23","author":"Goh","year":"2018","journal-title":"Nephrology"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib46","article-title":"Chronic myelomonocytic leukaemia: a presentation with rare extramedullary involvement","volume":"30","author":"Borges","year":"2016","journal-title":"Port J Nephrol Hypert"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib47","first-page":"120","article-title":"Lysozyme nephropathy: a rare and reversible cause of acute kidney injury in chronic myelomonocytic leukemia","volume":"5","author":"Donati","year":"2021","journal-title":"J\u00a0Onco-Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","article-title":"Uric acid and the kidney","volume":"29","author":"Fathallah-Shaykh","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/20009666.2020.1774271","article-title":"Transformation of CMML to AML presenting with acute kidney injury","volume":"10","author":"DeBoer","year":"2020","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.20497","article-title":"Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia","volume":"81","author":"Otrock","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.xkme.2023.100769_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-213095","article-title":"Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia","volume":"2016","author":"Langridge","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI108514","article-title":"A\u00a0micropuncture study of the early phase of acute urate nephropathy","volume":"58","author":"Conger","year":"1976","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.xkme.2023.100769_bib54","first-page":"467","article-title":"Leukemic urate nephropathy","volume":"99","author":"Kanwar","year":"1975","journal-title":"Arch Pathol"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib55","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1681\/ASN.2021070997","article-title":"Tumor lysis syndrome and AKI: beyond crystal mechanisms","volume":"33","author":"Arnaud","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"16","key":"10.1016\/j.xkme.2023.100769_bib56","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3-4","key":"10.1016\/j.xkme.2023.100769_bib57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10428199909050967","article-title":"Renal and adrenal gland localization of chronic myelomonocytic leukemia presenting as a kidney tumor","volume":"34","author":"Lieutaud","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib58","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/ndt\/12.7.1500","article-title":"Renal failure in a patient with chronic myelomonocytic leukaemia","volume":"12","author":"Robinson","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib59","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2009.07785.x","article-title":"Renal infiltration associated with chronic myelomonocytic leukaemia","volume":"147","author":"Kobayashi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.xkme.2023.100769_bib60","first-page":"1","article-title":"An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration","volume":"9","author":"Spapen","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.xkme.2023.100769_bib61","first-page":"1576","article-title":"Case report: uric acid nephropathy and myelomonocytic neoplastic renal infiltration in a patient with chronic myelomonocytic leukaemia and chronic kidney disease","author":"Robins","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.xkme.2023.100769_bib62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.leukres.2016.05.013","article-title":"Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: a series of 26 cases and literature review","volume":"47","author":"Grignano","year":"2016","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study","volume":"55","author":"Mekinian","year":"2016","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sarh.2001.27717","article-title":"Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia","volume":"31","author":"Hamidou","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib65","first-page":"486","article-title":"Vasculitis and neoplasms. 14 cases. Ann Med Interne (Paris)","volume":"142","author":"Fain","year":"1991"},{"issue":"10254","key":"10.1016\/j.xkme.2023.100769_bib66","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0140-6736(20)31905-X","article-title":"Extraordinary extrahaematological manifestations of chronic myelomonocytic leukaemia","volume":"396","author":"Stergiou","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0248-8663(89)80055-4","article-title":"Wegener\u2019s disease and myelomonocytic leukemia: a fortuitous association?","volume":"10","author":"Smail","year":"1989","journal-title":"Rev Med Interne"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib68","first-page":"221","article-title":"Medium-vessel PAN-type vasculitis associated with myelodysplastic syndrome and presenting as bilateral perinephric hematomas","volume":"15","author":"Brickner","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.xkme.2023.100769_bib69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijscr.2016.07.010","article-title":"Spontaneous bilateral renal aneurysm rupture secondary to polyarteritis nodosa in a patient with chronic myelomonocytic leukaemia: a case report study","volume":"26","author":"Georgiou","year":"2016","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib70","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1081\/JDI-120026038","article-title":"Bilateral renal infarction in chronic myelomonocytic leukemia on blast crisis","volume":"25","author":"Yen","year":"2003","journal-title":"Ren Fail"},{"key":"10.1016\/j.xkme.2023.100769_bib72","series-title":"Pulmonary Involvement in Patients with Hematological Malignancies","author":"Azoulay","year":"2011"},{"issue":"2","key":"10.1016\/j.xkme.2023.100769_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0735-6757(99)90073-6","article-title":"Leukemic hyperleukocytosis-induced unstable angina and congestive heart failure","volume":"17","author":"McCormick","year":"1999","journal-title":"Am J Emerg Med"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib74","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V97.7.2121","article-title":"Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination","volume":"97","author":"Stucki","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib75","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/1042819022386671","article-title":"Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure","volume":"43","author":"Stemmler","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib76","first-page":"33","article-title":"Renal involvement by chronic myelomonocytic leukemia requiring nephroureterectomy","volume":"11","author":"Hyams","year":"2009","journal-title":"Rev Urol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5858\/2001-125-0657-CMLRBU","article-title":"Chronic myelomonocytic leukemia revealed by uncontrollable hematuria","volume":"125","author":"Bane","year":"2001","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib78","first-page":"307","article-title":"Massive uric acid nephrolithiasis with progressive renal failure due to spontaneous tumour lysis syndrome","volume":"1","author":"Trachsler","year":"2008","journal-title":"NDT Plus"},{"issue":"10","key":"10.1016\/j.xkme.2023.100769_bib80","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1080\/10428194.2018.1427857","article-title":"Retroperitoneal fibrosis as extramedullary hematopoiesis of a chronic myelomonocytic leukemia","volume":"59","author":"Ricard","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.xkme.2023.100769_bib81","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jcp.51.4.340","article-title":"Obstructive uropathy associated with myelomonocytic infiltration of the prostate","volume":"51","author":"Hope-Gill","year":"1998","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.25684","article-title":"Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management","volume":"95","author":"Patnaik","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","article-title":"Anticancer drug-induced kidney disorders","volume":"24","author":"Kintzel","year":"2001","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V57.1.182.182","article-title":"5-Azacytidine and renal tubular dysfunction","volume":"57","author":"Peterson","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.xkme.2023.100769_bib85","series-title":"Epigenetic Regulation in Overcoming Chemoresistance","first-page":"9","article-title":"DNA methyltransferase inhibitors (DNMTis) as sensitizing agents to overcome chemoresistance","author":"Liu","year":"2021"},{"issue":"43","key":"10.1016\/j.xkme.2023.100769_bib86","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022901","article-title":"Decitabine-induced kidney thrombotic microangiopathy with glomerular crescents formation and tubular necrosis: a case report","volume":"99","author":"Qin","year":"2020","journal-title":"Medicine"},{"issue":"suppl 1","key":"10.1016\/j.xkme.2023.100769_bib87","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood-2022-167421","article-title":"Is renal function equally impacted by hypomethylating agents during acute myelogenous leukemia induction therapy?","volume":"140","author":"Otiker","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.xkme.2023.100769_bib88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrneph.2009.97","article-title":"Chemotherapy-associated renal dysfunction","volume":"5","author":"Sahni","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2023.100769_bib89","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1002\/ajh.25804","article-title":"Acute kidney injury after ruxolitinib: common complication, uncommon cause","volume":"95","author":"Strohbehn","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ackd.2013.07.004","article-title":"Kidney involvement in leukemia and lymphoma","volume":"21","author":"Luciano","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2023.100769_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051012","article-title":"Tumor lysis syndrome: an endless challenge in onco-nephrology","volume":"10","author":"Lupu\u0219oru","year":"2022","journal-title":"Biomedicines"},{"issue":"19","key":"10.1016\/j.xkme.2023.100769_bib93","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5 suppl 3","key":"10.1016\/j.xkme.2023.100769_bib94","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2009.10.056","article-title":"Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management","volume":"55","author":"Abu-Alfa","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2023.100769_bib95","article-title":"Tumor lysis syndrome in patients with hematological malignancies","volume":"2017","author":"Belay","year":"2017","journal-title":"J\u00a0Oncol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib96","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jha2.464","article-title":"Severe electrolyte derangements from lysozymuria in acute myeloid leukemia","volume":"3","author":"P\u00e9rez-Pinz\u00f3n","year":"2022","journal-title":"EJHaem"},{"issue":"6","key":"10.1016\/j.xkme.2023.100769_bib97","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archinte.1981.00340060094021","article-title":"Hypokalemia in nonblastic chronic myelogenous leukemia","volume":"141","author":"Evans","year":"1981","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib98","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0272-6386(12)70154-3","article-title":"Renal failure and severe hypokalemia associated with acute myelomonocytic leukemia","volume":"22","author":"Perazella","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2023.100769_bib99","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-9343(69)90219-8","article-title":"Lysozymuria and renal tubular dysfunction in monocytic and\u00a0myelomonocytic leukemia","volume":"47","author":"Muggia","year":"1969","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.xkme.2023.100769_bib100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1752-1947-9-16","article-title":"A\u00a0case of type B lactic acidosis as a complication of chronic myelomonocytic leukaemia: a case report and review of the literature","volume":"9","author":"Gardner","year":"2015","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.xkme.2023.100769_bib102","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fonc.2020.00779","article-title":"Electrolyte disorders induced by antineoplastic drugs","volume":"10","author":"Verzicco","year":"2020","journal-title":"Front Oncol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059523001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:26:09Z","timestamp":1762910769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059523001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2590059523001875"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100769","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100769"}}